Skip to content
Menu

Barclays Maintains Overweight on Elanco Animal Health, Raises Price Target to $32

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Glen Santangelo maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $30 to $32.

Barclays analyst Glen Santangelo maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $30 to $32.

Read at benzinga.com